Arrowhead Pharmaceuticals, Inc.

Pasadena, North Carolina, United States arrowheadpharma.com

Overview

Arrowhead Pharmaceuticals, Inc. is a biotechnology company focused on developing RNA interference (RNAi) therapeutics for the treatment of intractable diseases by silencing the genes that cause them. The company's proprietary Targeted RNAi Molecule (TRiM) platform is designed to enable tissue-specific delivery of RNAi therapeutics.

Therapeutic areas

CardiovascularMetabolicPulmonaryHepaticOncological

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Arrowhead Pharmaceuticals, Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.

Verified Supplier Partner

Is this Arrowhead Pharmaceuticals, Inc.? Get in front of buyers actively sourcing.

We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.

No cost to enquire · we only reach out with a fit.

Related companies

Ionis Pharmaceuticals, Inc.
United States
Otsuka Pharmaceutical Development & Commercialization, Inc.
United States
AstraZeneca do Brasil Ltda.
Brazil
ABC Biopharmaceuticals, Inc.
United States
Acceleron Pharma Inc.
United States
Celerion, Inc.
United States
Charles River Laboratories International, Inc.
United States
Corvidia Therapeutics, Inc.
United States

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.

Start free trialBook a demo